Display options
Share it on

Med Immunol. 2002 Nov 19;1(1):3. doi: 10.1186/1476-9433-1-3.

Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy.

Medical immunology (London, England)

Ashwani Khanna, Matthew Plummer, Katherine Bromberek, Jeffrey Woodliff, Sundaram Hariharan

Affiliations

  1. Department of Medicine (Nephrology), Medical College of Wisconsin, Milwaukee WI-53226, USA. [email protected]

PMID: 12495444 PMCID: PMC149406 DOI: 10.1186/1476-9433-1-3

Abstract

BACKGROUND: Long term treatment with immunosuppressive agents results in nephrotoxicity in renal transplant recipients. We explored the effect of combination of Tacrolimus (TAC) and Sirolimus (SRL) on the immune system in renal transplant recipients. METHODS: 10 stable renal transplant recipients were selected to participate in a pharmacokinetic study with a combination of TAC and SRL. Blood was drawn on day zero and 14 days post treatment. Lymphocyte proliferation was quantified by 3H-thymidine uptake assay (results expressed as counts per minute). The mRNA expression was studied by RT-PCR and serum levels of cytokines were quantified by ELISA and a cytokine bead array system. RESULTS: Lymphocyte proliferative response to PHA (p < 0.05), Con A (p < 0.006) and Anti-CD3 (p <0.005) were significantly decreased in patients who received both TAC and SRL compared to TAC alone. The mRNA expression of proinflammatory cytokines TNF-alpha (p < 0.05), cyclins G (p < 0.01) and E (p < 05) were decreased, and of TGF-beta (p < 0.03) and p21 (p < 0.05) were increased in patients treated with this combination. Circulating levels of IFN-gamma (p < 0.04), IL-4 (p < 0.02), and Il-2 (p < 0.03) were significantly inhibited and elevation of TGF-beta (p < 0.04) was observed in patients treated with TAC and SRL combination. CONCLUSION: These novel findings demonstrate that addition of SRL to TAC therapy enhances immuno modulation and causes increased immunosuppression providing a rationale for this concomitant therapy.

References

  1. Transplantation. 1999 Feb 27;67(4):614-9 - PubMed
  2. J Immunol. 1999 May 15;162(10):5829-37 - PubMed
  3. J Immunol. 2001 Mar 15;166(6):3789-96 - PubMed
  4. J Biol Chem. 1996 Mar 15;271(11):6050-61 - PubMed
  5. Transplantation. 2001 Mar 15;71(5):686-91 - PubMed
  6. Cell. 1991 Sep 20;66(6):1217-28 - PubMed
  7. Transplantation. 2000 Oct 27;70(8):1244-7 - PubMed
  8. J Thorac Cardiovasc Surg. 2001 Jul;122(1):29-38 - PubMed
  9. Clin Biochem. 1998 Jul;31(5):335-40 - PubMed
  10. Transplantation. 2000 Apr 15;69(7):1275-83 - PubMed
  11. Transplantation. 1993 Oct;56(4):831-5 - PubMed
  12. J Clin Invest. 1998 Jan 15;101(2):311-20 - PubMed
  13. Liver Transpl. 2001 May;7(5):401-8 - PubMed
  14. Drugs. 2000 Feb;59(2):323-89 - PubMed
  15. Clin Ther. 2000;22 Suppl B:B93-100 - PubMed
  16. Nature. 1984 Dec 20-1985 Jan 2;312(5996):724-9 - PubMed
  17. Transplantation. 1999 Mar 27;67(6):882-9 - PubMed
  18. Lancet. 2000 Jan 29;355(9201):376-7 - PubMed
  19. Transplantation. 2000 May 15;69(9):1759-66 - PubMed
  20. Nature. 1982 Feb 11;295(5849):503-8 - PubMed
  21. N Engl J Med. 1989 Dec 21;321(25):1725-38 - PubMed
  22. Microsurgery. 1999;19(7):344-7 - PubMed
  23. Transplantation. 2000 Aug 27;70(4):690-4 - PubMed
  24. Transplantation. 1997 Dec 27;64(12):1853-6 - PubMed
  25. Transplantation. 1998 Oct 27;66(8):1040-6 - PubMed
  26. Eur J Biochem. 1986 Sep 15;159(3):625-32 - PubMed
  27. Transplantation. 1999 May 15;67(9):1262-8 - PubMed
  28. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1172-6 - PubMed
  29. Kidney Int. 1996 Oct;50(4):1110-7 - PubMed

Publication Types